NCT07382544 2026-02-25
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
31 trialsNCT01087554 2026-01-16
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT04270864 2024-10-18
PRIMO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Terminated
NCT02193633 2024-09-26
TAX-TORC
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT02338622 2024-09-26
ComPAKT
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT05128539 2024-03-26
A Study Explore JS001+JS002 in Patients With Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT01954316 2024-01-17
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
University Health Network, Toronto
Phase 1 Completed
NCT05262842 2022-09-21
JS001+IMP4297 in Patients With Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Withdrawn
NCT01113476 2022-09-02
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03851146 2022-05-03
LeY-CAR-T
Peter MacCallum Cancer Centre, Australia
Phase 1 Completed
NCT01143779 2022-01-04
FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00543504 2020-06-30
Bevacizumab in Multiple Phase I Combinations
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01596140 2020-06-04
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03645200 2019-04-25
Treatment of Carrying TP53 Harmful Mutations
Tianjin Medical University Second Hospital
Phase 1 Unknown
NCT03554889 2018-06-13
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
Hangzhou Cancer Hospital
Phase 1 Unknown
NCT00610493 2017-12-08
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01339871 2017-06-16
Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00708773 2017-01-04
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
University of Chicago
Phase 1 Completed
NCT00940381 2015-11-18
Sirolimus and Cetuximab in Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01152203 2015-11-18
Bendamustine and Bevacizumab for Advanced Cancers
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01054313 2015-10-07
Docetaxel and Sirolimus in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00895128 2015-07-13
Study of Erlotinib in Combination With Dasatinib
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00530907 2015-01-08
Valproic Acid and Bevacizumab in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01693991 2014-07-10
Randomized Controlled Trial of the Meaning-Making Intervention (MMi)
Jewish General Hospital
Phase 1 Completed
NCT00707135 2014-01-17
Rapamycin in Advanced Cancers
University of Chicago
Phase 1 Completed
NCT00708591 2014-01-17
Study of Rapamycin Plus Ketoconazole in Advanced Cancers
University of Chicago
Phase 1 Completed
NCT00429234 2013-04-04
Gemcitabine and Dasatinib in Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00770731 2013-02-13
Study of Temsirolimus, Topotecan, and Bortezomib
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00955812 2013-02-12
STAT3 Inhibitor for Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00507962 2012-08-02
Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00508326 2012-07-30
Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement
M.D. Anderson Cancer Center
Phase 1 Completed